Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish® ...

A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...

It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...

One expert explains what patients with prostate cancer interested in clinical trial participation need to know. For patients with prostate cancer who are interested in participating in clinical trials ...

Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...

Application of canary histology classifier in prostate biopsies for risk stratification. Decipher genomic classifier (DGC) of early prostate cancer (EPC), and underlying transcriptomic profile (TP): ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.